Are agonistic autoantibodies against G-protein coupled receptors involved in the development of long-term side effects of tumor chemotherapy?

Case Reports in Oncology

Volumn 6, Issue 1, 2013, Pages 104-108

  Haberland, Annekathrin ^a   Santos, Robson A S ^c   Schimke, Ingolf ^a   Wallukat, Gerd ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Agonistic autoantibodies; Cardiomyopathy; Chemotherapy; G protein coupled receptor autoantibodies; Long term disturbances; Metabolic syndrome; Tumor therapy

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; ATROPINE; CISPLATIN; DOXORUBICIN; G PROTEIN COUPLED RECEPTOR; MUSCARINIC M2 RECEPTOR AGONIST; PACLITAXEL; PRAZOSIN; URAPIDIL;

ADULT; ADVERSE DRUG REACTION; ARTICLE; BIOASSAY; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CASE REPORT; CHRONOTROPISM; DIARRHEA; FEMALE; HUMAN; HYPERTENSION; LONG TERM CARE; MEASUREMENT; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; POLYNEUROPATHY; PRIORITY JOURNAL;

EID: 84877952956     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000348425     Document Type: Article

References (15)

1. Kobold S, Lütkens T, Cao Y, Bokemeyer C, Atanackovic D: Autoantibodies against tumor-related antigens: incidence and biologic significance. Hum Immunol 2010;71:643-651.
2. Conrad K, Bartsch H, Canzler U, Pilarsky C, Grützmann R, Bachmann M: Search for and identification of novel tumor-associated autoantigens. Methods Mol Biol 2010;576:213-230.
3. Xia Y, Kellems RE: Receptor-activating autoantibodies and disease: preeclampsia and beyond. Expert Rev Clin Immunol 2011;7:659-674.
4. Ferrari I, Levin MJ, Wallukat G, Elies R, Lebesgue D, Chiale P, Elizari M, Rosenbaum M, Hoebeke J: Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med 1995;182:59-65.
5. Wallukat G, Wollenberger A: Cultivated cardiac muscle cells-a functional test system for the detection of autoantibodies against the beta-adrenergic receptor (in German). Acta Histochem Suppl 1988;35:145-149.
6. Ewer MS, Ewer SM: Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nat Rev Cardiol 2010;7:564-575.
7. Yoon GJ, Telli ML, Kao DP, Matsuda KY, Carlson RW, Witteles RM: Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies: are clinicians responding optimally? J Am Coll Cardiol 2010;56:1644-1650.
8. Nuver J, Smit AJ, Wolffenbuttel BH, Sluiter WJ, Hoekstra HJ, Sleijfer DT, Gietema JA: The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 2005;23:3718-3725.
9. Ersvaer E, Bertelsen LT, Espenes LC, Bredholt T, Bøe SO, Iversen BM, Bruserud Ø, Ulvestad E, Gjertsen BT: Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease. Scand J Immunol 2004;60:189-198.
10. Sterin-Borda L, Goin JC, Bilder CR, Iantorno G, Hernando AC, Borda E: Interaction of human chagasic IgG with human colon muscarinic acetylcholine receptor: molecular and functional evidence. Gut 2001;49: 699-705.
11. Luther HP, Homuth V, Wallukat G: Alpha 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension 1997;29:678-682.
12. Hempel P, Karczewski P, Kohnert KD, Raabe J, Lemke B, Kunze R, Bimmler M: Sera from patients with type 2 diabetes contain agonistic autoantibodies against G protein-coupled receptors. Scand J Immunol 2009;70:159-160.
13. Santos RA, Ferreira AJ, Simões E, Silva AC: Recent advances in the angiotensin-converting enzyme2-angiotensin(1-7)-Mas axis. Exp Physiol 2008;93:519-527.
14. Dandel M, Wallukat G, Englert A, Lehmkuhl HB, Knosalla C, Hetzer R: Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy. Eur J Heart Fail 2012;14:1374-1388.
15. Haberland A, Wallukat G, Dahmen C, Kage A, Schimke I: Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies. Circ Res 2011;109:986-992.